TrialThe oncologist2023

Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial.

Shouki Bazarbashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.